ADAP
Adaptimmune Therapeutics
ADAP
ADAP
80 hedge funds and large institutions have $144M invested in Adaptimmune Therapeutics in 2024 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 22 increasing their positions, 15 reducing their positions, and 12 closing their positions.
Holders
80
Holders Change
+4
Holders Change %
+5.26%
% of All Funds
1.16%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.03%
New
16
Increased
22
Reduced
15
Closed
12
Calls
$107K
Puts
$6K
Net Calls
+$101K
Net Calls Change
+$4K